At an 8 a.m. EST press conference today at the American Heart Association meeting, UB professor of medicine William E. Boden, MD, discusses the AIM-HIGH clinical trial, which found that niacin provides no incremental benefit to patients with atherosclerotic heart disease, whose levels of LDL cholesterol and non-HDL (which contributes to plaque in the arteries) were very well-controlled.